scholarly journals Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine

2014 ◽  
Vol 12 (1) ◽  
pp. 25 ◽  
Author(s):  
Sung Kim ◽  
Anni-Maria Pulkki-Brannstrom ◽  
Jolene Skordis-Worrall
BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e041346
Author(s):  
Leopold Ndemnge Aminde ◽  
Linda Cobiac ◽  
J. Lennert Veerman

BackgroundReducing dietary sodium (salt) intake has been proposed as a population-wide strategy to reduce blood pressure and cardiovascular disease (CVD). The cost-effectiveness of such strategies has hitherto not been investigated in Cameroon.MethodsA multicohort multistate life table Markov model was used to evaluate the cost-effectiveness of three population salt reduction strategies: mass media campaign, school-based salt education programme and low-sodium salt substitute. A healthcare system perspective was considered and adults alive in 2016 were simulated over the life course. Outcomes were changes in disease incidence, mortality, health-adjusted life years (HALYs), healthcare costs and incremental cost-effectiveness ratios (ICERs) over the lifetime. Probabilistic sensitivity analysis was used to quantify uncertainty.ResultsOver the life span of the cohort of adults alive in Cameroon in 2016, substantial numbers of new CVD events could be prevented, with over 10 000, 79 000 and 84 000 CVD deaths that could be averted from mass media, school education programme and salt substitute interventions, respectively. Population health gains over the lifetime were 46 700 HALYs, 348 800 HALYs and 368 400 HALYs for the mass media, school education programme and salt substitute interventions, respectively. ICERs showed that all interventions were dominant, with probabilities of being cost-saving of 84% for the school education programme, 89% for the mass media campaign and 99% for the low sodium salt substitute. Results were largely robust in sensitivity analysis.ConclusionAll the salt reduction strategies evaluated were highly cost-effective with very high probabilities of being cost-saving. Salt reduction in Cameroon has the potential to save many lives and offers good value for money.


2021 ◽  
Author(s):  
Andrew Briggs ◽  
Beth Wehler ◽  
Jennifer G. Gaultney ◽  
Alex Upton ◽  
Antoine Italiano ◽  
...  

Addiction ◽  
2010 ◽  
Vol 105 (2) ◽  
pp. 319-328 ◽  
Author(s):  
Lorna Guinness ◽  
Peter Vickerman ◽  
Zahidul Quayyum ◽  
Anna Foss ◽  
Charlotte Watts ◽  
...  

2012 ◽  
Vol 155 ◽  
pp. 128-135 ◽  
Author(s):  
Matthew M. McConnachie ◽  
Richard M. Cowling ◽  
Brian W. van Wilgen ◽  
Dominic A. McConnachie

PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0192132 ◽  
Author(s):  
Borja G. Reguero ◽  
Michael W. Beck ◽  
David N. Bresch ◽  
Juliano Calil ◽  
Imen Meliane

2019 ◽  
Vol 39 (7) ◽  
pp. 842-856
Author(s):  
Ji-Hee Youn ◽  
Matt D. Stevenson ◽  
Praveen Thokala ◽  
Katherine Payne ◽  
Maria Goddard

Introduction. Individuals from older populations tend to have more than 1 health condition (multimorbidity). Current approaches to produce economic evidence for clinical guidelines using decision-analytic models typically use a single-disease approach, which may not appropriately reflect the competing risks within a population with multimorbidity. This study aims to demonstrate a proof-of-concept method of modeling multiple conditions in a single decision-analytic model to estimate the impact of multimorbidity on the cost-effectiveness of interventions. Methods. Multiple conditions were modeled within a single decision-analytic model by linking multiple single-disease models. Individual discrete event simulation models were developed to evaluate the cost-effectiveness of preventative interventions for a case study assuming a UK National Health Service perspective. The case study used 3 diseases (heart disease, Alzheimer’s disease, and osteoporosis) that were combined within a single linked model. The linked model, with and without correlations between diseases incorporated, simulated the general population aged 45 years and older to compare results in terms of lifetime costs and quality-adjusted life-years (QALYs). Results. The estimated incremental costs and QALYs for health care interventions differed when 3 diseases were modeled simultaneously (£840; 0.234 QALYs) compared with aggregated results from 3 single-disease models (£408; 0.280QALYs). With correlations between diseases additionally incorporated, both absolute and incremental costs and QALY estimates changed in different directions, suggesting that the inclusion of correlations can alter model results. Discussion. Linking multiple single-disease models provides a methodological option for decision analysts who undertake research on populations with multimorbidity. It also has potential for wider applications in informing decisions on commissioning of health care services and long-term priority setting across diseases and health care programs through providing potentially more accurate estimations of the relative cost-effectiveness of interventions.


Sign in / Sign up

Export Citation Format

Share Document